|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/00 | (2006.01) |
| A61K2039/505 | (2013.01) | ||
| A61K 39/395 | (2006.01) | ||
| C07K 16/2866 | (2013.01) | ||
| G01N 33/48 | (2006.01) | ||
| A61P 11/06 | (2018.01) | ||
| A61P 11/06 | (2006.01) | ||
| C07K2317/76 | (2013.01) |
| (11) | Number of the document | 3536339 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19162585.4 |
| Date of filing the European patent application | 2014-08-07 | |
| (97) | Date of publication of the European application | 2019-09-11 |
| (45) | Date of publication and mention of the grant of the patent | 2021-10-06 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201361864950 P | 2013-08-12 | US |
| (72) |
WARD, Christine , US
ROSKOS, Lorin , US
WANG, Bing , US
RAIBLE, Donald , US
|
| (73) |
Astrazeneca AB ,
151 85 Södertälje,
SE
|
| (54) | METHODS FOR IMPROVING ASTHMA SYMPTOMS USING BENRALIZUMAB |
| METHODS FOR IMPROVING ASTHMA SYMPTOMS USING BENRALIZUMAB |